<?xml version="1.0" encoding="UTF-8"?><xml><records><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Tugce Schmitt</style></author><author><style face="normal" font="default" size="100%">Marie Delnord</style></author><author><style face="normal" font="default" size="100%">Emilie Cauët</style></author><author><style face="normal" font="default" size="100%">Els Van Valckenborgh</style></author><author><style face="normal" font="default" size="100%">Marc Van den Bulcke</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Contextual factors influencing the equitable implementation of precision medicine in routine cancer care in Belgium</style></title><secondary-title><style face="normal" font="default" size="100%">European Journal of Public Health</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Belgium</style></keyword><keyword><style  face="normal" font="default" size="100%">budgets</style></keyword><keyword><style  face="normal" font="default" size="100%">cancer</style></keyword><keyword><style  face="normal" font="default" size="100%">cancer care facilities</style></keyword><keyword><style  face="normal" font="default" size="100%">contextual factors</style></keyword><keyword><style  face="normal" font="default" size="100%">Demography</style></keyword><keyword><style  face="normal" font="default" size="100%">economics</style></keyword><keyword><style  face="normal" font="default" size="100%">ethics</style></keyword><keyword><style  face="normal" font="default" size="100%">genomicsn health expenditures medical oncology</style></keyword><keyword><style  face="normal" font="default" size="100%">health care systems</style></keyword><keyword><style  face="normal" font="default" size="100%">Precision</style></keyword><keyword><style  face="normal" font="default" size="100%">Precision Medicine</style></keyword><keyword><style  face="normal" font="default" size="100%">privacy</style></keyword><keyword><style  face="normal" font="default" size="100%">public health medicine</style></keyword><keyword><style  face="normal" font="default" size="100%">Reimbursement Mechanisms</style></keyword><keyword><style  face="normal" font="default" size="100%">transfer technique</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2024</style></year><pub-dates><date><style  face="normal" font="default" size="100%">Apr-03-2026</style></date></pub-dates></dates><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p&gt;&lt;strong&gt;Background&lt;/strong&gt;&lt;/p&gt;

&lt;p&gt;Precision medicine represents a paradigm shift in health systems, moving from a one-size-fits-all approach to a more individualized form of care, spanning multiple scientific disciplines including drug discovery, genomics, and health communication. This study aims to explore the contextual factors influencing the equitable implementation of precision medicine in Belgium for incorporating precision medicine into routine cancer care within the Belgian health system.&lt;/p&gt;

&lt;p&gt;&lt;strong&gt;Methods&lt;/strong&gt;&lt;/p&gt;

&lt;p&gt;As part of a foresight study, our approach evaluates critical factors affecting the implementation of precision oncology. The study scrutinizes contextual, i.e. demographic, economic, societal, technological, environmental, and political/policy-related (DESTEP) factors, identified through a comprehensive literature review and validated by a multidisciplinary group at the Belgian Cancer Center, Sciensano. An expert survey further assesses the importance and likelihood of these factors, illuminating potential barriers and facilitators to implementation.&lt;/p&gt;

&lt;p&gt;&lt;strong&gt;Results&lt;/strong&gt;&lt;/p&gt;

&lt;p&gt;Based on the expert survey, five key elements (rising cancer rates, dedicated healthcare reimbursement budgets, increasing healthcare expenditures, advanced information technology solutions for data transfer, and demand for high-quality data) are expected to influence the equitable implementation of precision medicine in routine cancer care in Belgium in the future.&lt;/p&gt;

&lt;p&gt;&lt;strong&gt;Conclusions&lt;/strong&gt;&lt;/p&gt;

&lt;p&gt;This work contributes to the knowledge base on precision medicine in Belgium and public health foresight, exploring the implementation challenges and suggesting solutions with an emphasis on the importance of comparative analyses of health systems, evaluation of health technology assessment methods, and the exploration of ethical issues in data privacy and equity.&lt;/p&gt;
</style></abstract></record></records></xml>